GeoVax Labs, Inc. (GOVX)
0.206
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.2035
0.00 (0.00%)
After-Hours: 20:00
GeoVax Labs Price to Book Value : 0.8622 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.8622 |
| October 22, 2026 | 0.8902 |
| October 21, 2026 | 0.9718 |
| October 20, 2026 | 0.9505 |
| October 19, 2026 | 0.9522 |
| October 16, 2026 | 0.9974 |
| October 15, 2026 | 1.079 |
| October 14, 2026 | 1.010 |
| October 13, 2026 | 1.112 |
| October 12, 2026 | 1.182 |
| October 09, 2026 | 1.176 |
| October 08, 2026 | 1.200 |
| October 07, 2026 | 1.211 |
| October 06, 2026 | 1.208 |
| October 05, 2026 | 1.339 |
| October 02, 2026 | 1.340 |
| October 01, 2026 | 1.348 |
| September 30, 2026 | 1.398 |
| September 29, 2026 | 1.473 |
| September 28, 2026 | 1.447 |
| September 25, 2026 | 1.469 |
| September 24, 2026 | 1.508 |
| September 23, 2026 | 1.582 |
| September 22, 2026 | 1.520 |
| September 21, 2026 | 1.501 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.494 |
| September 17, 2026 | 1.603 |
| September 16, 2026 | 1.696 |
| September 15, 2026 | 1.752 |
| September 14, 2026 | 1.801 |
| September 11, 2026 | 1.938 |
| September 10, 2026 | 1.948 |
| September 09, 2026 | 1.962 |
| September 08, 2026 | 1.959 |
| September 04, 2026 | 2.022 |
| September 03, 2026 | 2.121 |
| September 02, 2026 | 2.312 |
| September 01, 2026 | 2.535 |
| August 31, 2026 | 2.647 |
| August 28, 2026 | 3.018 |
| August 27, 2026 | 3.001 |
| August 26, 2026 | 2.637 |
| August 25, 2026 | 2.687 |
| August 24, 2026 | 2.872 |
| August 21, 2026 | 2.702 |
| August 20, 2026 | 2.520 |
| August 19, 2026 | 2.489 |
| August 18, 2026 | 2.723 |
| August 17, 2026 | 2.741 |
| August 14, 2026 | 3.005 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.32 |
| Anika Therapeutics, Inc. | 2.088 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.376 |
Price to Book Value Related Metrics
| Price | 0.206 |
| Earnings Yield | -6.76K% |
| Market Cap | 1.518M |